More than 200 human papillomavirus (HPV) types have been identified, but only 12 are carcinogenic. The 9-valent HPV vaccine targets seven carcinogenic types (HPV16, 18, 31, 33, 45, 52, and 58), including HPV16/18, which account for most HPV-associated cancers. However, HPV35, 39, 51, 56, and 59 are not covered by...
Morgan C. Byrd, Mary Ho, Qi-Yao Mak et al.· Cancer Epidemiology, Biomark...· 0 citations
Following the KEYNOTE-689 presentation in 2025, neoadjuvant immunotherapy has become an integral component of perioperative treatment for head and neck squamous cell carcinoma (HNSCC). As pathologic response is increasingly used to assess treatment efficacy, we evaluated rates of pathologic complete response (pCR...
A. Rustad, T. Omer, Morgan C. Byrd et al.· Cancer Epidemiology, Biomark...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.